Latest news
Loading news…
Bionetix Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Suwon, Ch'ungch'ong-namdo, South Korea Founded 2017 1-10 employees For Profit
Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
Company Info
- Founded
- 2017
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- HQ
- Suwon, Ch'ungch'ong-namdo, South Korea
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.1
- Trend (30d)
- -0.2
- Trend (90d)
- -0.5
Key People at Bionetix Therapeutics
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Bionetix Therapeutics
Loading news…
FAQs about Bionetix Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.